Disorders of water and acid-base homeostasis

Nephron - Physiology

Volumn 118, Issue 1, 2010, Pages

  Karet, Fiona E ^a,b  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b ADDENBROOKE S HOSPITAL   (United Kingdom)

Author keywords

Nephrogenic diabetes insipidus; Polarized epithelia; Renal tubular acidosis; Renal tubule

Indexed keywords

AMILORIDE; BICARBONATE; CITRATE POTASSIUM; NONSTEROID ANTIINFLAMMATORY AGENT; NUCLEOBASE TRANSPORTER; SPIRONOLACTONE; THIAZIDE DIURETIC AGENT; WATER;

ACIDOSIS; ALKALOSIS; BONE MARROW TRANSPLANTATION; CLINICAL FEATURE; CONSTIPATION; DEHYDRATION; DISORDERS OF ACID BASE BALANCE; FAILURE TO THRIVE; GENETIC DISORDER; GENETICS; GLUCOSURIA; GROWTH RETARDATION; HEALTH CARE; HOMEOSTASIS; HUMAN; HYPERTHERMIA; HYPOKALEMIA; HYPONATREMIA; HYPOPHOSPHATEMIA; IMPLANTATION; ION TRANSPORT; KIDNEY TUBULE ACIDOSIS; MALOCCLUSION; MENTAL DEFICIENCY; METABOLIC ACIDOSIS; NEPHROGENIC DIABETES INSIPIDUS; OSTEOMALACIA; PRIORITY JOURNAL; PROTEINURIA; REVIEW; RICKETS; SALT INTAKE; SHORT STATURE; VISUAL IMPAIRMENT; VITAMIN D DEFICIENCY; VOMITING;

ACID-BASE IMBALANCE; ANIMALS; FANCONI SYNDROME; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HOMEOSTASIS; HUMANS; KIDNEY DISEASES; KIDNEY TUBULES, PROXIMAL; MODELS, GENETIC;

EID: 78649935283     PISSN: 16602137     EISSN: None     Source Type: Journal    
DOI: 10.1159/000320885     Document Type: Review

References (32)

1. Makaryus AN, McFarlane SI: Diabetes in-sipidus: diagnosis and treatment of a complex disease. Cleve Clin J Med 2006; 73: 65-71.
2. Arthus MF, Lonergan M, Crumley MJ, Nau-mova AK, Morin D, De Marco LA, Kaplan BS, Robertson GL, Sasaki S, Morgan K, Bi-chet DG, Fujiwara TM: Report of 33 novel AVPR2 mutations and analysis of 117 families with X-linked nephrogenic diabetes in-sipidus. J Am Soc Nephrol 2000; 11:1044-1054.
3. Deen PM, Van Os CH, Knoers NVAM: Nephrogenic diabetes insipidus: aquapo-rin-2 defect; in Lifton R P, Somlo S, Giebisch GH, Seldin DW (eds): Genetic Diseases of the Kidney. Burlington, Academic Press, 2009, pp 351-362.
4. Nomura Y, Onigata K, Nagashima T, Yutani S, Mochizuki H, Nagashima K, Morikawa A: Detection of skewed X-inactivation in two female carriers of vasopressin type 2 receptor gene mutation. J Clin Endocrinol Metab 1997; 82: 3434-3437.
5. Bichet DG, Birnbaumer M, Lonergan M, Ar-thus MF, Rosenthal W, Goodyer P, Nivet H, Benoit S, Giampietro P, Simonetti S, et al: Nature and recurrence of AVPR2 mutations in X-linked nephrogenic diabetes insipidus. Am J Hum Genet 1994; 55:278-286.
6. Morello JP, Salahpour A, Laperrière A, Bernier V, Arthus MF, Lonergan M, Petäjä-Repo U, Angers S, Morin D, Bichet DG, Bouvier M: Pharmacological chaperones rescue cell-surface expression and function of misfolded V2 vasopressin receptor mutants. J Clin Invest 2000; 105:887-895.
7. Bernier V, Morello JP, Zarruk A, Debrand N, Salahpour A, Lonergan M, Arthus MF, La-perrière A, Brouard R, Bouvier M, Bichet DG: Pharmacologic chaperones as a potential treatment for X-linked nephrogenic diabetes insipidus. J Am Soc Nephrol 2006; 17: 232-243.
8. Hendriks G, Koudijs M, Van Balkom BW, Oorschot V, Klumperman J, Deen PM, Van Der Sluijs P: Glycosylation is important for cell surface expression of the water channel aquaporin-2 but is not essential for tetramer-ization in the endoplasmic reticulum. J Biol Chem 2004; 279 : 2975-2983.
9. Bichet D: Nephrogenic diabetes insipidus: vasopressin receptor defect; in Lifton R P, Somlo S, Giebisch GH, Seldin DW (eds): Genetic Diseases of the Kidney. Burlington, Academic Press, 2009, pp 341-349.
10. Laing CM, Unwin RJ: Renal tubular acidosis. J Nephrol 2006; 19(suppl 9):S46-S52.
11. Igarashi T, Inatomi J, Sekine T, Cha SH, Ka-nai Y, Kunimi M, Tsukamoto K, Satoh H, Shimadzu M, Tozawa F, Mori T, Shiobara M, Seki G: Endou H: Mutations in SLC4A4 cause permanent isolated proximal renal tubular acidosis with ocular abnorma lities. Nat Genet 1999; 23: 264-265.
12. Attree O, Olivos IM, Okabe I, Bailey LC, Nelson DL, Lewis RA, McInnes RR, Nussbaum RL: The Lowe's oculocerebrorenal syndrome gene encodes a protein highly homologous to inositol polyphosphate-5-phosphatase. Nature 1992; 358: 239-242.
13. Hoopes RR Jr, Shrimpton AE, Knohl SJ, Hueber P, Hoppe B, Matyus J, Simckes A, Ta-sic V, Toenshoff B, Suchy SF, Nussbaum RL, Scheinman SJ: Dent disease with mutations in OCRL1. Am J Hum Genet 2005; 76: 260-267.
14. Town M, Jean G, Cherqui S, Attard M, For-estier L, Whitmore SA, Callen DF, Gribouval O, Broyer M, Bates GP, van't Hoff W, Antig-nac C: A novel gene encoding an integral membrane protein is mutated in nephro-pathic c ystinosis. Nat Genet 1998; 18: 319-324.
15. Bruce LJ, Cope DL, Jones GK, Schofield AE, Burley M, Povey S, Unwin RJ, Wrong O, Tanner MJ: Familial distal renal tubular acidosis is associated with mutations in the red cell anion exchanger (band 3, AE1) gene. J Clin Invest 1997; 100: 1693-1707.
16. Wrong O, Bruce LJ, Unwin R, Toye AM, Tanner MJ: Band 3 mutations, distal renal tubular acidosis, and Southeast Asian ovalocyto-sis. Kidney Int 2002; 62: 10-19.
17. Duncan BK, Miller JH: Mutagenic deamina-tion of cytosine residues in DNA. Nature 198 0; 2 87: 560-561.
18. Rungroj N, Devonald MA, Cuthbert AW, Re-imann F, Akkarapatumwong V, Yenchit-somanus PT, Bennett WM, Karet FE: A novel missense mutation in AE1 causing autosomal dominant distal renal tubular ac-idosis retains normal transport function but is mistargeted in polarized epithelial cells. J Biol Chem 2004; 279: 13833-13838.
19. Devonald MA, Smith AN, Poon JP, Ihrke G, Karet FE: Non-polarized targeting of AE1 causes autosomal dominant distal renal tubular acidosis. Nat Genet 2003; 33:125-127.
20. Toye AM, Banting G, Tanner MJ: Regions of human kidney anion exchanger 1 (kAE1) required for basolateral targeting of kAE1 in polarised kidney cells: mis-targeting explains dominant renal tubular acidosis (dRTA). J Cell Sci 2004; 117:1399-1410.
21. Schwartz GJ: Diagnosis of distal renal tubular acidosis: use of furosemide plus fludro-cortisone versus ammonium chloride. Nat Clin Pract Nephrol 2007; 3: 590-591.
22. Györy AZ, Edwards KD: Renal tubular aci-dosis. A family with an autosomal dominant genetic defect in renal hydrogen ion transport, with proximal tubular and collecting duct dysfunction and increased metabolism of citrate and ammonia. Am J Med 1968; 45: 43-62.
23. Smith AN, Skaug J, Choate KA, Nayir A, Bakkaloglu A, Ozen S, Hulton SA, Sanjad SA, Al-Sabban EA, Lifton RP, Scherer SW Karet FE: Mutations in ATP6N1B, encoding a new kidney vacuolar proton pump 116-kD subunit, cause recessive distal renal tubular acidosis with preserved hearing. Nat Genet 2000; 26: 71-75.
24. +-ATPase cause renal tubular acidosis with sensorineural deafness. Nat Genet 1999; 21:84-90.
25. Fuster DG, Zhang J, Xie XS, Moe OW: The vacuolar-ATPase B1 subunit in distal tubular acidosis: novel mutations and mechanisms for dysfunction. Kidney Int 2008; 73: 1151-1158.
26. Stover EH, Borthwick KJ, Bavalia C, Eady N, Fritz DM, Rungroj N, Giersch AB, Morton CC, Axon PR, Akil I, Al-Sabban EA, Baguley DM, Bianca S, Bakkaloglu A, Bircan Z, Chauveau D, Clermont MJ, Guala A, Hulton SA, Kroes H, Li Volti G, Mir S, Mocan H, Nayir A, Ozen S, Rodriguez Soriano J, Sanjad SA, Tasic V, Taylor CM, Topaloglu R, Smith AN, Karet FE: Novel ATP6V1B1 and ATP-6V0A4 mutations in autosomal recessive distal renal tubular acidosis with new evidence for hearing loss. J Med Genet 2002; 39: 796-803.
27. Vargas-Poussou R, Houillier P, Le Pottier N, Strompf L, Loirat C, Baudouin V, Macher MA, Déchaux M, Ulinski T, Nobili F, Eckart P, Novo R, Cailliez M, Salomon R, Nivet H, Cochat P, Tack I, Fargeot A, Bouissou F, Kes-ler GR, Lorotte S, Godefroid N, Layet V, Mo-rin G, Jeunemaître X, Blanchard A: Genetic investigation of autosomal recessive distal renal tubular acidosis: evidence for early sen-sorineural hearing loss associated with mutations in the ATP6V0A4 gene. J Am Soc Nephrol 2006; 17: 14 37-144 3.
28. Joshua B, Kaplan DM, Raveh E, Lotan D, Anikster Y: Audiometric and imaging characteristics of distal renal tubular acidosis and deafness. J Laryngol Otol 2008; 122: 193-198.
29. Sly WS, Hewett-Emmett D, Whyte MP, Yu Y-SL, Tashian RE: Carbonic anhydrase II deficiency identified as the primary defect in the autosomal recessive syndrome of osteo-petrosis with renal tubular acidosis and cerebral calcification. Proc Natl Acad Sci 1983; 80:2752-2756.
30. Roth DE, Venta PJ, Tashian RE, Sly WS: Molecular basis of human carbonic anhydrase II deficiency. Proc Natl Acad Sci USA 1992; 89: 1804-1808.
31. Borthwick KJ, Kandemir N, Topaloglu R, Kornak U, Bakkaloglu A, Yordam N, Ozen S, Mocan H, Shah GN, Sly WS, Karet FE: A phe-nocopy of CAII deficiency: a novel genetic explanation for inherited infantile osteope-trosis with distal renal tubular acidosis. J Med Genet 2003; 40:115-121.
32. McMahon C, Will A, Hu P, Shah GN, Sly WS, Smith OP: Bone marrow transplantation corrects osteopetrosis in the carbonic anhy-drase II deficiency syndrome. Blood 2001; 97: 1947-1950.